January 22, 2018 / 5:59 PM / 6 months ago

BRIEF-Pulmatrix Announces Acceptance Of A Clinical Trial Application In Europe For Pulmazole

Jan 22 (Reuters) - Pulmatrix Inc:

* PULMATRIX ANNOUNCES ACCEPTANCE OF A CLINICAL TRIAL APPLICATION IN EUROPE FOR PULMAZOLE - AN INHALED DRY-POWDER ISPERSE™ FORMULATION OF ITRACONAZOLE

* PULMATRIX INC - EXPECTS THAT TOP LINE RESULTS FOR PUR1900 STUDY WILL BE AVAILABLE IN MID-2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below